Assessment and Management of Anti-Insulin Autoantibodies in Varying Presentations of Insulin Autoimmune Syndrome
Author(s) -
David Church,
Luís Cardoso,
Richard G. Kay,
Claire Williams,
Bernard Freudenthal,
Catriona Clarke,
Julie Harris,
Myuri Moorthy,
Efthmia Karra,
Fiona M. Gribble,
Frank Reimann,
Keith Burling,
Alistair J.K. Williams,
Alia Munir,
T. Hugh Jones,
Dagmar Führer,
Lars C. Moeller,
Mark L. Cohen,
Bernard Khoo,
David Halsall,
Robert K. Semple,
Dagmar FührerSakel
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-00972
Subject(s) - insulin , medicine , context (archaeology) , autoantibody , endocrinology , radioimmunoassay , hypoglycemia , hyperinsulinemic hypoglycemia , antibody , immunology , biology , paleontology
Insulin autoimmune syndrome (IAS), spontaneous hyperinsulinemic hypoglycemia due to insulin-binding autoantibodies, may be difficult to distinguish from tumoral or other forms of hyperinsulinemic hypoglycemia, including surreptitious insulin administration. No standardized treatment regimen exists.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom